Moreover, decreased expression of Mek1/2 and p-Erk1/2 was observed after treatment with KW-2478 in CML cells (Fig. 5g). The gene discussed is MAP2K1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.